Phreesia, Inc.
NYSE:PHRMedical - Healthcare Information Services
+$0.08 today
- Market cap
- $760.99M
- Beta
- 0.88
- P/E (TTM)
- 62.6
- EPS (TTM)
- $0.15
Volume 0.86M
Average 1.97M
PHR Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Phreesia, Inc.NYSE: PHR
Free Cash Flow · Q1 FY2027 · quarter ended Apr 2026
Free cash flow grows, but more slowly than its trailing trend
Q1 FY2027 free cash flow of $17.35M rose 132.7% year over year, behind the +189.3% change in trailing-twelve-month free cash flow. Sequentially, it fell 44.2% from the prior quarter.
Context
- Free cash flow amounted to 14.1% of revenue in FY2026, up 12.1 pp from a year earlier.
- Free cash flow increased in 3 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +132.7% toward the trailing-twelve-month pace of +189.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2026
- 67.71M USD
- Year-over-year change
- +716.6%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 67.71M | +716.6% |
| FY2025 | 2025-01-31 | 8.29M | +114.4% |
| FY2024 | 2024-01-31 | (57.48M) | +50.6% |
| FY2023 | 2023-01-31 | (116.33M) | -10.2% |
| FY2022 | 2022-01-31 | (105.52M) | — |
Free Cash Flow vs competitors
How PHR compares with its peers on the latest reported figures
- PHR's LTM Apr 2026 free cash flow of $73.72M is the 6th largest of the 11 companies compared; the peer median is $9.83M.
- Its year-over-year change of +189.3% is the 3rd highest of 11, against a peer median of +28.5%.
- Free cash flow amounts to 14.9% of revenue for PHR, versus a peer median of 8.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $251.09M | +21.7% | +18.2% | 10.0% | |
| LTM Mar 2026 | $131.64M | +39.2% | +21.5% | 16.7% | |
| LTM Jan 2026 | $119.95M | +35.4% | — | 143.3% | |
| LTM Sep 2026 | $116.77M | +3339.6% | — | 43.4% | |
| LTM Mar 2026 | $111.77M | -4.1% | +72.1% | 9.1% | |
| LTM Apr 2026 | $73.72M | +189.3% | — | 14.9% | |
| LTM Aug 2026 | $49.75M | +1677.8% | — | 5.6% | |
| LTM Mar 2026 | $48.07M | -33.4% | — | 7.1% | |
| LTM Sep 2026 | $22.04M | -71.6% | -12.6% | 8.3% | |
| LTM Mar 2026 | $21.45M | +163.1% | — | 7.6% | |
| LTM Mar 2026 | $1.79M | -115.9% | — | 1.8% | |
| Peer median (excluding PHR) | $9.83M | +28.5% | +19.9% | 8.7% | |
Competitors are the stored peer set for PHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | (118.16M) | (176.15M) | (136.89M) | (58.53M) | 2.31M |
| Depreciation & Amortization | 21.3M | 25.3M | 29.49M | 27.89M | 31.45M |
| Deferred Income Tax | 143K | 434K | 228K | 214K | (13.27M) |
| Stock-Based Compensation | 36.14M | 58.78M | 71.7M | 66.98M | 67.45M |
| Change in Working Capital | (18.57M) | (3.86M) | (1.64M) | (6.49M) | (14.09M) |
| Accounts Receivables | (10.22M) | (11.13M) | (11.21M) | (8.81M) | (10.15M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 2.88M | 4.77M | (1.99M) | (3.23M) | 5.26M |
| Other Working Capital | (11.24M) | 2.5M | 11.56M | 5.55M | (9.2M) |
| Other Non-Cash Items | 4.43M | 5.37M | 4.73M | 2.33M | 4.96M |
| Operating Cash Flow | (74.71M) | (90.12M) | (32.38M) | 32.38M | 78.81M |
| Capital Expenditures | (30.81M) | (26.2M) | (25.1M) | (24.09M) | (11.1M) |
| Acquisitions (Net) | (34.42M) | 0 | (14.57M) | 0 | (153.19M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 15.71M |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (12.39M) | (21.47M) | (19.29M) | (15.38M) | (13.3M) |
| Investing Cash Flow | (65.23M) | (26.2M) | (39.67M) | (24.09M) | (161.88M) |
| Debt Repayment | (4.27M) | (5.95M) | (6.78M) | (7.81M) | 83.18M |
| Common Stock Issued | 245.81M | 4.92M | 0 | 3.93M | 3.83M |
| Common Stock Repurchased | (9M) | (19.38M) | (12.18M) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.42M | (397K) | 1.84M | (7.61M) | (14.15M) |
| Financing Cash Flow | 234.97M | (20.8M) | (17.12M) | (11.49M) | 72.85M |
| Effect of Forex Changes | 0 | 0 | 0 | (106K) | (176K) |
| Net Change in Cash | 95.03M | (137.13M) | (89.16M) | (3.3M) | (10.39M) |
| Free Cash Flow | (105.52M) | (116.33M) | (57.48M) | 8.29M | 67.71M |
Phreesia, Inc.
NYSE:PHR
Intrinsic Alpha fair value
Locked
Current Price
$12.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.